Suraksha Diagnostic Limited IPO: Key Dates, Price Band and More

Home » Investing » IPO » Suraksha Diagnostic Limited IPO: Key Dates, Price Band and More

Suraksha Diagnostic Limited launched its IPO on November 29, 2024. This book-built issue aims to raise ₹846.25 crores through an offer for the sale of 1.92 crore shares. Shares are priced between ₹420 and ₹441 per share, with a minimum IPO lot size of 34 shares. The IPO allotment is expected on December 4, 2024, with the listing on BSE and NSE scheduled for December 6, 2024.

Get Started with the Suraksha Diagnostic IPO Application!

Suraksha Diagnostic IPO (Tentative Timeline)

Key DetailInformation
SymbolSURAKSHA
IPO Opening DateNovember 29, 2024
IPO Closing DateDecember 3, 2024
Listing DateDecember 6, 2024
Face Value₹2 per share
Price Range₹420 to ₹441 per share
Minimum Order Quantity34 Equity Shares
Maximum Subscription Amount₹200000
Total Issue Size19,189,330 Equity Shares
IPO SegmentBook Built Issue IPO
Book Running Lead ManagersICICI Securities Limited, Nuvama Wealth Management Limited and SBI Capital Markets Limited
RegistrarKfin Technologies Ltd.
Listing AtBSE, NSE

Brief Introduction to Suraksha Diagnostic Limited

Suraksha Diagnostic Limited was incorporated in 2005. It provides a wide range of pathology, radiology testing, and medical consultancy services. With a strong presence in Eastern and Northeastern India, the company operates a central reference laboratory, 8 satellite laboratories, and 215 customer touchpoints.

As of 2024, its main services include:

  • Pathology and Radiology Testing
  • Medical Consultancy and Online/Offline Services
  • Vaccination Services and Customized Testing Packages
  • Digital Pathology and AI-based Blood Test Analysis
  • Diagnostic Centres and Polyclinics

 Apply for Suraksha Diagnostic IPO with a free demat account and zero AMC fees!

Suraksha Diagnostic IPO: Key Details

  • Suraksha Diagnostic Limited IPO Launch Date: November 29, 2024
  • Suraksha Diagnostic Limited IPO Closing Date: December 3, 2024
  • Suraksha Diagnostic Limited IPO Allotment Date: December 4, 2024
  • Suraksha Diagnostic IPO Price Band: ₹420 to ₹441 per share
  • Suraksha Diagnostic IPO Lot Size: 34 shares
  • Suraksha Diagnostic IPO Face Value: ₹2 per share
  • Refunds Initiated: December 5, 2024
  • Shares Credited to Demat: December 5, 2024
  • Suraksha Diagnostic IPO Listing Date: December 6, 2024

Suraksha Diagnostic: Year-on-Year Financial Overview and Growth Highlights

As per the latest reports, Suraksha Diagnostic Limited’s revenue grew by 14.75%. Additionally, its profit after tax (PAT) jumped by 281.32% from the financial year ending on March 31, 2023, to March 31, 2024.

Here is a look at the overall financial performance of the company in the past few years:

Amount in ₹ Crore

YearAssets (₹ Cr)Revenue (₹ Cr)Profit After Tax (PAT) (₹ Cr)Net Worth (₹ Cr)Reserves and Surplus (₹ Cr)
2024₹314.20₹61.85₹7.67₹187.05₹176.80
2023₹300.21₹222.26₹23.13₹179.41₹170.88
2022₹281.20₹193.69₹6.07₹155.93₹147.40
2021₹275.96₹225.77₹20.82₹145.84₹137.31

FAQs – Suraksha Diagnostic IPO

What is Suraksha Diagnostic Limited?

Suraksha Diagnostic offers pathology, radiology, and medical consultancy services with a presence in Eastern India.

When is the Suraksha Diagnostic IPO bidding date?

The IPO will be open for subscription from November 29 to December 3, 2024.

What is the IPO lot size for Suraksha Diagnostic?

The IPO lot size is 34 shares.

When will the Suraksha Diagnostic IPO allotment be finalized?

The Suraksha Diagnostic Limited IPO allotment date is December 4, 2024.

How to check the Suraksha Diagnostic IPO allotment status?

You can check the allotment status on the registrar’s website, Kfin Technologies Ltd.

When is the Suraksha Diagnostic IPO listing date?

The tentative IPO listing date is December 6, 2024.

Who is the registrar for the IPO?

The registrar for Suraksha Diagnostic IPO is Kfin Technologies Ltd.

What is the price band for this IPO?

The price band for the Suraksha Diagnostic IPO is ₹420 to ₹441 per share.

______________________________________________________________________________________

Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.